(INNS)
BRONTIKTUZUMAB(INNC)
IMMUNOGLOBULIN G2-LAMBDA, ANTI-[HOMO SAPIENS NOTCH1 (NOTCH 1, TRANSLOCATION-ASSOCIATED NOTCH-1, TAN-1,TAN1)], HUMANIZED MONOCLONAL ANTIBODY; GAMMA2 HEAVY CHAIN (1-447) [HUMANIZED VH (HOMO SAPIENS IGHV1-24*01 (80.40%) -(IGHD)-IGHJ4*01 L123>T (116)) [8.8.14] (1-121) -HOMO SAPIENS IGHG2*01 (CH1 (122-219), HINGE (220-231), CH2 (232-340), CH3 (341- 445), CHS (446-447)) (122-447)],(135-214')-DISULFIDE WITH LAMBDA LIGHT CHAIN (1'-215') [HUMANIZED V-LAMBDA (HOMO SAPIENS IGLV7-46*01 (83.20%) -IGLJ2*01) [9.3.9] (1'-109') -HOMO SAPIENS IGLC7*01 (110'-215')]; DIMER (223- 223'':224-224'':227-227'':230-230'')-TETRAKISDISULFIDE, RECOMMENDED INN: LIST 73(WHO)
BRONTICTUZUMABUM(INN)